Medicaid Coverage

Does Medicaid Cover GLP-1 Medications?

Medicaid coverage for GLP-1 medications varies significantly by state, as each state administers its own Medicaid program. Most state Medicaid programs cover Ozempic and Mounjaro for type 2 diabetes. Coverage for weight management medications (Wegovy, Zepbound) is less consistent but expanding, with several states adding coverage in 2025-2026.

Reviewed by GlobalGLP1 Editorial Team • Updated April 2026 • Sources: publicly available formulary data

Medication Coverage

Medication Status Tier Notes
Ozempic (semaglutide) Covered Preferred Drug List (most states) Covered for type 2 diabetes in virtually all state Medicaid programs. Prior authorization typically required.
Wegovy (semaglutide) Varies Varies by state FDA-approved for weight management. Some states cover for weight loss, others exclude anti-obesity medications entirely. Coverage expanding as more states recognize obesity as a treatable condition.
Mounjaro (tirzepatide) Covered Preferred Drug List (most states) Covered for type 2 diabetes in most states. Some states prefer Mounjaro over Ozempic.
Zepbound (tirzepatide) Varies Varies by state FDA-approved for weight management. Limited state Medicaid coverage. Newer medication still being added to state formularies.
Saxenda (liraglutide) Varies Non-preferred (most states) Limited coverage. Many states have restricted or removed Saxenda from their formularies.
Compounded semaglutide Not Covered N/A Not covered by any state Medicaid program.

Prior Authorization

All state Medicaid programs require prior authorization for GLP-1 medications. Requirements vary by state but typically include a diagnosis code, BMI documentation, and evidence of previous treatment attempts. Processing times range from 24 hours to 2 weeks depending on the state.

Cost Estimates

With Insurance
$0-$8/prescription (Medicaid copays are minimal)
Without Insurance
$800-$1,400/month

Savings tip: Medicaid copays are capped by federal law — typically $0-$8 per prescription depending on your state and income level. If you qualify for Medicaid, GLP-1 medications are among the most affordable options.

Requirements for Coverage

  • Active Medicaid enrollment in your state
  • Meet your state's Medicaid eligibility requirements
  • Prior authorization from your state Medicaid program or MCO
  • Type 2 diabetes or obesity diagnosis (coverage varies by state for weight management)
  • Some states require use of Medicaid-preferred pharmacy

Tips for Getting Approved

1

Contact your state Medicaid office or managed care organization (MCO) to check your specific formulary

2

Medicaid managed care plans (like Molina, Centene, Amerigroup) may have different formularies than fee-for-service Medicaid

3

If your state doesn't cover weight management GLP-1s, ask about coverage through Medicaid expansion programs

4

Patient assistance programs from Novo Nordisk and Eli Lilly may supplement Medicaid coverage

5

Telehealth GLP-1 prescribers may accept Medicaid — check our directory for Medicaid-accepting clinics

Approval Statistics

Initial Approval
30-50% (diabetes), 10-20% (weight management)
Appeal Success
20-30%
Processing Time
15-45 business days

Medicaid GLP-1 coverage varies dramatically by state. Some states (New York, California) have broader formularies, while others severely restrict or exclude GLP-1 medications. Processing times tend to be longer than commercial insurance.

Common Denial Reasons & How to Avoid Them

State formulary exclusion Common Denial

How to avoid: Check your state's Medicaid preferred drug list (PDL). If your GLP-1 isn't listed, ask your doctor to request a non-preferred drug authorization or switch to the preferred alternative.

Anti-obesity medication not covered Common Denial

How to avoid: Most state Medicaid programs do not cover anti-obesity medications. Some states are adding coverage under ACA expansion. Check with your state Medicaid office for current status.

Prior authorization denied Common Denial

How to avoid: Medicaid prior auth requires thorough documentation. Include all diagnoses, BMI history, comorbidities, and previous treatment failures. Request help from your clinic's billing department.

Provider not enrolled in Medicaid Common Denial

How to avoid: Your prescribing provider must be enrolled as a Medicaid provider. Verify enrollment before your appointment to avoid coverage issues.

Step Therapy Requirements

Ozempic / Mounjaro (diabetes)

Most states require: metformin first-line, then sulfonylurea or SGLT2. GLP-1 approval typically requires A1C >8% (stricter than commercial) despite dual oral therapy.

Wegovy / Zepbound (weight management)

Rarely covered by Medicaid. States with coverage require extensive documentation including 6-12 months of supervised weight management, BMI 35+ (higher threshold than commercial), and multiple comorbidities.

Frequently Asked Questions

Yes, virtually all state Medicaid programs cover Ozempic for type 2 diabetes. Prior authorization is required. Contact your state Medicaid office or MCO to confirm formulary placement and any restrictions.

Medicaid coverage for Wegovy (weight management) varies by state and changes frequently. States with broader coverage include New York, California, and several others. Many states are adding coverage as federal guidance evolves. Contact your state Medicaid program for current coverage status.

Medicaid copays are minimal by law — typically $0 to $8 per prescription. Some states have zero copays for all prescriptions. Your out-of-pocket cost will be significantly less than commercial insurance.

Yes, most Medicaid managed care organizations (MCOs) cover GLP-1 medications for diabetes. Coverage for weight management varies by MCO and state. Each MCO has its own formulary, so check with your specific plan.

Medicaid coverage for FDA-approved weight management medications like Wegovy and Zepbound varies significantly by state. Some states have added these medications to their preferred drug lists, while others continue to exclude anti-obesity medications. Contact your state Medicaid office for the most current information.

In many states, you can switch MCOs during open enrollment periods or within 90 days of initial enrollment. Different MCOs within the same state may have different formularies. Contact your state Medicaid office to learn about your plan switching options and compare MCO formularies.

Some GLP-1 medications are FDA-approved for adolescents aged 12 and older (including Wegovy). Medicaid coverage for minors varies by state and may have different requirements than adult coverage. Pediatric obesity treatment is an area of expanding coverage. Check with your state Medicaid program for specific pediatric policies.

Get Started

Find a GLP-1 Clinic That Takes Your Insurance

Search our directory of 2,770 clinics and filter by insurance, medication, and telehealth availability.

Disclaimer: Insurance coverage information is based on publicly available formulary data and may not reflect your specific plan. Coverage, cost, and requirements can change. Always verify with your insurer directly before making treatment decisions.